| back to ACTB products | | | This is a review about beta-actin antibodies, based on 38 published articles using beta-actin antibodies in western blot, immunohistochemistry, immunoprecipitation, immunocytochemistry, and other immunological technologies. It is aimed to help ExactAntigen visitors find the most suited beta-actin antibody. Information in this review (with links to publications) can be searched freely. |
SIGMA search SIGMA ACTB products
Other Brands or Spellings: SIGMA-ALDRICH, SIGMA CHEMICAL, SIGMA CHEMICAL COMPANY, SIGMA-ALDRICH FINE CHEMICALS |
Beta actin antibody is one of most commonly used Western Blot loading control, and the beta actin antibody from Sigma is the most widely applied antibody. It has also been used in immunocytochemistry.
Sigma monoclonal anti-actin antibody was used in immunocytochemistry in 2003 by Zubin Master et al. to study the interaction of Dok-R and c-Abl and cytoskeletal reorganization, and in 2005 by Laura Lynch et al. to study cell adhesion mediated by alpha5beta1 integrins in motile carcinoma cells. Sigma monoclonal anti-actin antibody was used in Western blot, mostly as an internal loading control in 2000 by S Nakamura et al to detect p53, WAF1 and MDM2, in 2004 by Jinhu Yin et al. to study RECQL4 in nucleus and cytoplasm of HeLa cells, in 2002 by Eun Ran Suh et al. to study CDX1 gene expression in colorectal cancer cell lines, in 2005 by Zsuzsanna Orbán-Németh et al. to characterize microtubule-associated protein 1S, in 2005 by An-Sheng Zhang et al. to study the iron accumulation in human embryonic kidney 293 cells, in 2005 by N A C S Wong et al. to study the CDX1, and in 2005 by Alessandra Alberghini et al. to investigate the effect of von Hippel Lindau tumor suppressor on iron homeostasis in renal carcinoma cells.
Sigma rabbit polyclonal anti-actin antibody was used in western blot, as an internal loading control as well, in 2004 by Lynne Cassimeris et al. to study TOGp in centrosome integrity,spindle pole organization and bipolar spindle assembly, in 2005 by Bernard Dublet et al. to investigate PR3-mediated p21 cleavage, and n 2005 by Kohsuke Kanekura et al. to study Cu/Zn-superoxide dismutase (SOD1) mutant-induced motoneuronal cell death.
In addition, Sigma antiactin antibody (AC-15) have been used in western blot in 2005 by Christopher C Valley et al. to investigate the regulation of ER alpha proteolysis and transcription, by Jing-Xu Zhu et al. to serve as a control, by Nikos Tapinos et al. to investigate the activation of Erk1/2 by intracellular M. leprae, by Manish K Tripathi et al. to study BRCA2 gene expression in human breast cells, by Andrew V Samuelson et al. to study that E1A-induced apoptosis, by Jianmin Zhang et al. to study that Cdc42 and RhoB activation, by Andrew B West et al. to study leucine-rich repeat kinase 2, by Karim Kaabeche et al. to study the functional link between FGFR2 signaling and Cbl-mediated alpha-5-integrin expression, by Annett Hahn-Windgassen et al. to investigate the interactin among Akt, mTOR, and AMPK, and in 2006 by Hui Wang et al. to study the relation between overexpression of ribosomal protein L15 and cell proliferation in gastric cancer. |
USBIOLOGICAL search USBIOLOGICAL ACTB products
Other Brands or Spellings: US BIOLOGICAL |
| In 2003 Weidong Wu et al. used USBiological beta-actin antibody in western blot to study zinc-induced PTEN protein degradation |
SANTA CRUZ BIOTECHNOLOGY
Other Brands or Spellings: SANTA CRUZ, SANTA CRUZ BIOTECH, SANTA CRUZ BIOTECHNOLOGY INC., SANTA CRUZ BIOTECHNOLOGY INC, SANTZ CRUZ, SANTA CRUZ BIOTECHNOLOGIES |
|
Santa Cruz Biotechnology goat anti-actin antibody was used in western blot in 2002 by Jennifer A Benanti et al. to study the APA-1-induced extracellular matrix-remodeling genes, and in 2005 by Xinbo Liao et al. to study apoptotic cell death in prostate cancer caused by androgen receptor silencing, by Juan Wang et al.to study the immortalization of bovine lens epithelial cells by human telomerase reverse transcriptase, and by Shravanti Rampalli et al. to study that cyclin D1 repression.
|
| ABCAM |
| In 2003 Stefanie Galbán et al. used Abcam monoclonal b-actin antibody in western blot to study von Hippel-Lindau protein-mediated repression of tumor necrosis factor alpha translation.
|
LAB VISION
Other Brands or Spellings: LABVISION, NEOMARKERS, NEOMARKER, LAB VISION/NEOMARKERS |
| Mark W Jackson et al. used its beta-actin antibody in western blot to study p130/p107/p105Rb-dependent transcriptional repression during DNA-damage-induced cell-cycle exit at G2 in 2005. In 2006 A Persson et al. tested Lab Vision/NeoMarkers ACTB antibody in immunohistochemistry in the HPA (CAB002621) project, Sylvia Major et al. tested Lab Vision (Pan)Actin antibody in western blot in the Abminer project. |
| ICN |
| In 2004, Jun Zhang et al. used ICN monoclonal anti-beta-actin antibody in western blot to study a novel candidate tumor suppressor gene for breast cancer, cystatin M. |
ZYMED LABORATORIES
Other Brands or Spellings: INVITROGEN, BIOSOURCE, BIOSOURCE INTERNATIONAL, ZYMED, CALTAG, MOLECULAR PROBES, MEDGENIX DIAGNOSTICS, MEDGENIX, DYNAL ASA |
| In 2005, Scott K Kuwada et al. used Zymed Laboratories actin monoclonal antibody in western blot to study HER-2 down-regulation in colon cancer cells. |
BOEHRINGER
|
| In 2005, Cheng Zhang et al. used Boehringer Mannheim beta-actin antibody in western blot as a control to investigate the repression of RNA polymerase I transcription by PTEN, and Hu Xu et al. used the beta-actin antibody as an internal control as well in western blot to study the inhibition EGFR family members in colon and breast cancer cells.
|
| CYTOSKELETON |
| In 2005, Jean M Camden et al. used Cytoskeleton goat anti-human actin antibody in western blot as a loading control to study the effect of P2Y2 nucleotide receptors on alpha-secretase-dependent amyloid precursor protein processing.
|
Articles Reviewed | | 1. S Nakamura et al. Multiple lysine mutations in the C-terminal domain of p53 interfere with MDM2-dependent protein degradation and ubiquitination. 2000 | | 2. Eun Ran Suh et al. DNA methylation down-regulates CDX1 gene expression in colorectal cancer cell lines. 2002 | | 3. Jennifer A Benanti et al. Induction of extracellular matrix-remodeling genes by the senescence-associated protein APA-1. 2002 | | 4. Monique C A Duyndam et al. Evidence for a role of p38 kinase in hypoxia-inducible factor 1-independent induction of vascular endothelial growth factor expression by sodium arsenite. 2003 | | 5. Stefanie Galbán et al. von Hippel-Lindau protein-mediated repression of tumor necrosis factor alpha translation revealed through use of cDNA arrays. 2003 | | 6. Weidong Wu et al. Zinc-induced PTEN protein degradation through the proteasome pathway in human airway epithelial cells. 2003 | | 7. Zubin Master et al. Dok-R binds c-Abl and regulates Abl kinase activity and mediates cytoskeletal reorganization. 2003 | | 8. Lynne Cassimeris et al. TOGp, the human homolog of XMAP215/Dis1, is required for centrosome integrity, spindle pole organization, and bipolar spindle assembly. 2004 | | 9. Jinhu Yin et al. RECQL4, mutated in the Rothmund-Thomson and RAPADILINO syndromes, interacts with ubiquitin ligases UBR1 and UBR2 of the N-end rule pathway. 2004 | | 10. Jun Zhang et al. Cystatin m: a novel candidate tumor suppressor gene for breast cancer. 2004 | | 11. Laura Lynch et al. Insulin-like growth factor I controls adhesion strength mediated by alpha5beta1 integrins in motile carcinoma cells. 2005 | | 12. Zsuzsanna Orbán-Németh et al. Microtubule-associated protein 1S, a short and ubiquitously expressed member of the microtubule-associated protein 1 family. 2005 | | 13. Jianmin Zhang et al. Cdc42 and RhoB activation are required for mannose receptor-mediated phagocytosis by human alveolar macrophages. 2005 | | 14. Kohsuke Kanekura et al. A Rac1/phosphatidylinositol 3-kinase/Akt3 anti-apoptotic pathway, triggered by AlsinLF, the product of the ALS2 gene, antagonizes Cu/Zn-superoxide dismutase (SOD1) mutant-induced motoneuronal cell death. 2005 | | 15. Karim Kaabeche et al. Cbl-mediated ubiquitination of alpha5 integrin subunit mediates fibronectin-dependent osteoblast detachment and apoptosis induced by FGFR2 activation. 2005 | | 16. Manish K Tripathi et al. Regulation of BRCA2 gene expression by the SLUG repressor protein in human breast cells. 2005 | | 17. Andrew V Samuelson et al. p400 is required for E1A to promote apoptosis. 2005 | | 18. Scott K Kuwada et al. Integrin alpha5/beta1 expression mediates HER-2 down-regulation in colon cancer cells. 2005 | | 19. Hu Xu et al. Epidermal growth factor receptor (EGFR)-related protein inhibits multiple members of the EGFR family in colon and breast cancer cells. 2005 | | 20. Jean M Camden et al. P2Y2 nucleotide receptors enhance alpha-secretase-dependent amyloid precursor protein processing. 2005 | | 21. Mark W Jackson et al. p130/p107/p105Rb-dependent transcriptional repression during DNA-damage-induced cell-cycle exit at G2. 2005 | | 22. Xinbo Liao et al. Small-interfering RNA-induced androgen receptor silencing leads to apoptotic cell death in prostate cancer. 2005 | | 23. Juan Wang et al. Human telomerase reverse transcriptase immortalizes bovine lens epithelial cells and suppresses differentiation through regulation of the ERK signaling pathway. 2005 | | 24. N A C S Wong et al. CDX1 is an important molecular mediator of Barrett's metaplasia. 2005 | | 25. Christopher C Valley et al. Differential regulation of estrogen-inducible proteolysis and transcription by the estrogen receptor alpha N terminus. 2005 | | 26. Nikos Tapinos et al. Insights into regulation of human Schwann cell proliferation by Erk1/2 via a MEK-independent and p56Lck-dependent pathway from leprosy bacilli. 2005 | | 27. Bernard Dublet et al. Cleavage of p21/WAF1/CIP1 by proteinase 3 modulates differentiation of a monocytic cell line. Molecular analysis of the cleavage site. 2005 | | 28. Sima Salahshor et al. Differential gene expression profile reveals deregulation of pregnancy specific beta1 glycoprotein 9 early during colorectal carcinogenesis. 2005 | | 29. Alessandra Alberghini et al. Loss of the von Hippel Lindau tumor suppressor disrupts iron homeostasis in renal carcinoma cells. 2005 | | 30. Jing-Xu Zhu et al. Decorin evokes protracted internalization and degradation of the epidermal growth factor receptor via caveolar endocytosis. 2005 | | 31. Annett Hahn-Windgassen et al. Akt activates the mammalian target of rapamycin by regulating cellular ATP level and AMPK activity. 2005 | | 32. Cheng Zhang et al. PTEN represses RNA Polymerase I transcription by disrupting the SL1 complex. 2005 | | 33. An-Sheng Zhang et al. Interaction of hemojuvelin with neogenin results in iron accumulation in human embryonic kidney 293 cells. 2005 | | 34. Shravanti Rampalli et al. Tumor suppressor SMAR1 mediates cyclin D1 repression by recruitment of the SIN3/histone deacetylase 1 complex. 2005 | | 35. Andrew B West et al. Parkinson's disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity. 2005 | | 36. Sylvia Major et al. AbMiner: a bioinformatic resource on available monoclonal antibodies and corresponding gene identifiers for genomic, proteomic, and immunologic studies. 2006 | | 37. Hui Wang et al. Overexpression of ribosomal protein L15 is associated with cell proliferation in gastric cancer. 2006 | | 38. A Persson et al. A human protein atlas based on antibody proteomics. 2006 |
|